Clathrin-mediated endocytosis (CME) is the best-characterized mechanism governing cellular membrane and protein trafficking. In this hypothesis review, we integrate recent evidence implicating CME and related cellular trafficking mechanisms in the pathophysiology of psychotic disorders such as schizophrenia and bipolar disorder. The evidence includes proteomic and genomic findings implicating proteins and genes of the clathrin interactome. Additionally, several important candidate genes for schizophrenia, such as dysbindin, are involved in processes closely linked to CME and membrane trafficking. We discuss that key aspects of psychosis neuropathology such as synaptic dysfunction, white matter changes and aberrant neurodevelopment are all influenced by clathrin-dependent processes, and that other cellular trafficking mechanisms previously linked to psychoses interact with the clathrin interactome in important ways. Furthermore, many antipsychotic drugs have been shown to affect clathrin-interacting proteins. We propose that the targeted pharmacological manipulation of the clathrin interactome may offer fruitful opportunities for novel treatments of schizophrenia.
Introduction
Our understanding of the core pathophysiology of schizophrenia remains poor. While documented genetic and environmental risk factors have provided clues, they have not identified the precise cellular processes that are responsible for the development of the disorder. What emerges is a somewhat complex picture of a polygenic basis to schizophrenia, which is strongly modulated by environmental factors. 1 There has been a focus on understanding the pathophysiology of schizophrenia and bipolar disorder in terms of signaling pathways. Thus, pathway analysis of genomic, transcriptomic or proteomic findings is now commonplace and a part of most investigations. One difficulty with such analyses is that they rely on the classic and often rather arbitrary definition of canonical pathways in biology. However, it is increasingly clear that these pathways interact with each other in complex and often in relatively poorly understood ways. Ascribing biological significance to isolated pathways in complex disorders is therefore bound to overlook possible overlapping functional significance. New approaches are needed in order to account for the complexity of the gene and protein interactions, including the application of systems proteomics and systems biology approaches. 2 In this hypothesis review, we describe the potential relevance of the cellular process of membrane and protein trafficking in psychosis pathophysiology. Based on unbiased systems proteomics and genetic studies, we propose that there is now solid evidence for disturbances of proteins interacting with the membrane vesicle coat protein clathrin. We outline how clathrin-mediated cellular processes such as clathrin-mediated endocytosis (CME) and endosomal protein sorting and trafficking could have a significant influence on many documented aspects of psychosis neuropathology, indicating that they may represent a common functional endpoint of many small molecular 'lesions'. We suggest that a reevaluation of findings from the available 'omics' platforms, seeking convergence across different study domains, may prove a fruitful strategy in the search for causes and therapies for complex psychiatric illnesses.
Endocytic mechanisms control the lipid and protein composition of the plasma membrane, thereby regulating how cells interact with their environments. CME and lipid raft-mediated endocytosis represent the two main endocytic routes. CME is the best-characterized endocytic pathway 3 (see Figure 1 ). In CME, clathrininteracting proteins recruit cargo molecules at the bilayer membrane into developing clathrin-coated pits, and subsequently form clathrin-coated vesicles for intracellular trafficking of cargo. The network of proteins involved, and the mechanisms of proteinprotein interactions are becoming increasingly well understood. Temporal and spatial network analysis have led to a pathway model of CME, 4, 5 in which the central 'hub' proteins clathrin and adaptor protein complex 2 (AP-2) interact with a multitude of accessory players, the so-called CME interactome, depending on cargo and other circumstances.
Once endocytosed, uncoating of clathrin occurs and the vesicles form early endosomes. These can either recycle directly back to the plasma membrane, transfer to recycling endosomes or enter the late endosomal/lysomal pathway for degradation. The route taken is, at least in part, determined by members of the Rab family of GTPases, 6 which are associated with distinct endosomal populations and which are central to ensuring that vesicle cargos find their correct destinations. 7, 8 Apart from their role in CME, AP-2-and clathrininteracting proteins are involved in a wide network of cellular processes, including endosomal sorting, 9 lysosome biogenesis, 10 mitosis, 11 antigen presentation 12 and cell migration. 13 Members of the CME interactome also have a role in the regulation of many intracellular signaling cascades, 14 and CME is exploited by pathogens to mediate their internalization into cells. 15 CME proteins and proteins governing cellular trafficking processes have been implicated in proteomic investigations of psychotic disorders, undertaken by our group [16] [17] [18] [19] [20] and others. 16, 19, 21, 22 While trafficking changes in schizophrenia have been considered previously, [23] [24] [25] a specific role for the clathrin interactome has not been discussed. We therefore reviewed the proteomic and genomic literature for a potential role of CME, and membrane trafficking generally, in psychosis. We further searched for evidence, linking endocytosis with key features of psychosis pathophysiology, namely synaptic function, white matter integrity and neurodevelopment, and studies linking the pharmacology of antipsychotic drugs with endocytic mechanisms.
Postmortem proteomic investigations find evidence for altered clathrin-interacting proteins in psychotic disorders
Proteomic investigations of postmortem tissue of subjects with psychotic disorders have revealed altered levels of several clathrin-and AP-2-interacting Figure 1 Clathrin-mediated endocytosis is characterized by assembly of a coat of clathrin and adaptor proteins such as adaptor protein complex 2 (AP-2) at endocytic membrane sites containing cargo proteins. The sites then form clathrin-coated pits, which are separated from the membrane by scission protein dynamin and its associated machinery. The clathrin-coated vesicle (CCV) is transported intracellularly along actin structures. After uncoating, CCVs merge with early endosomes, and cargo is further processed either for degradation or recycling back to the cell surface.
proteins. 16, 19, 22 In our own studies, we have identified changes in dynamin-1, 17, 18 amphiphysin, 16 AP-2 component alpha adaptin 20 and HSC 70. 17 A review of the literature indicates that at least 25% of the clathrin interactome proteins as defined by Schmid and McMahon 4 have been implicated in postmortem or serum proteomic work to date (see Table 1 ). We then expanded our search to non-clathrin-interacting proteins, which are involved in the regulation of vesicle scission, actin assembly, vesicle uncoating, tethering of vesicles to early endosomes and vesicleendosome fusion (for overview see ref. 26) , and have included these in our literature review (see Supplementary Table 1 ).
Genetic associations find evidence for altered clathrin-interacting genes in psychotic disorders
Genetic studies show that psychosis candidate genes either encode proteins of the clathrin interactome directly, or proteins that are closely functionally linked to clathrin-dependent processes (see Table 1 ). Particularly strong evidence implicates the clathrin interactome genes Epsin 4 and Stonin 2. Several clathrin interactome genes are included in the top 1000 variations identified by genome-wide association studies to date. 27 Clathrin-interacting proteins Stonin 2 and Epsin 4 are implicated by direct genetic association Stonin 2 has recently been identified as a susceptibility gene for schizophrenia. 28 It is a member of the clathrin interactome and acts as an endocytic adaptor protein for the retrieval of the surface synaptic vesicle protein synaptotagmin. Genetic association between schizophrenia and the Epsin 4 gene was demonstrated in independent samples in the UK, 29 China 30 and Latin America. 31 Epsin 4, also known as EpsinR, codes for enthoprotin (CLINT1), which interacts with clathrin, AP-1 and GGA2 during coated vesicle formation at endosomal membranes. [32] [33] [34] Additional domains of the enthoprotin molecule allow for complex recognition and differential trafficking of ubiquinated molecules within the cell. 35 Enthoprotin also interacts with a soluble-N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE), which is implicated in schizophrenia. [36] [37] [38] Several psychosis candidate genes are functionally linked to clathrin-dependent processes Dysbindin is encoded by the DTNBP1 gene, one of the best supported candidate genes for schizophrenia. 39, 40 Dysbindin is a key member of the biogenesis of lysosome-related organelles complex (BLOC-1), which influences presynaptic membrane trafficking, glutamate exocytosis, vesicle biogenesis and SNARE protein-mediated membrane fusion. 41 Vesicular trafficking of SNARE proteins and BLOC-1 components are clathrin-dependent, 42 and members of the CME interactome appear to mediate their functional properties. 43 Additionally, downregulation of dysbindin disrupts the BLOC-1/AP-3 complex and causes diversion of dopamine D2 receptor (D2R) trafficking from the lysosomal to the recycling pathway. 41, 44, 45 Further, upregulation of dysbindin has been shown to lead to reduced cell surface expression of the NR1 subunit and to N-methyl-D-aspartate (NMDA) hypofunction, an effect reversed by pharmacological inhibition of CME, suggesting that dysbindin regulates clathrin-dependent NMDA trafficking. 46 Another BLOC-1 constituent, Muted, is also associated with increased risk of schizophrenia. 47 Further, schizophrenia candidate gene DISC1 is a key interactor with the protein product of the mutated gene in Huntington's Disease, huntingtin (htt). 48 Htt acts through clathrin-dependent mechanisms to regulate synaptic vesicle fusion. Calcineurin is also strongly implicated in schizophrenia, 49 and it acts through clathrin-dependent endocytosis to regulate growth cone guidance. 50 Further, the brain and primate specific 3.1 isoform of the KCNH2 potassium channel also shows genetic association in schizophrenia, 51 and is regulated by dynamin-dependent endocytosis. 52 The schizophrenia candidate genes neuregulin, ERBB4 and protein phosphatase PP2B have roles in postsynaptic NMDAR trafficking 53 by regulating phosphorylation of NMDAR subunits NR2A and NR2B, and stimulating clathrin-dependent receptor internalization. 54, 55 These findings raise the possibility that altered protein trafficking may be one shared functional endpoint directly or indirectly influenced by many candidate genes, which contribute to schizophrenia risk.
Key aspects of schizophrenia neuropathology are mediated by CME Altered CME may contribute to synaptic pathology In the nervous system, CME is crucially involved in the signaling mechanisms of the synapse. CME is important for both presynaptic and postsynaptic functions, and both functions have been implicated in schizophrenia. [56] [57] [58] [59] In presynaptic axon terminals, CME is required for the retrieval of synaptic vesicle proteins following neurotransmitter release, and for the recycling of vesicles back to the reserve pool. 8 Also, in presynaptic terminals, protein kinase C (PKC)-induced internalization of dopamine transporter from the synapse is clathrin-and dynamindependent. 60 The dopamine transporter is located in presynaptic terminals and facilitates dopamine reuptake from the synaptic cleft, thereby regulating signal strength (for review see ref. 61) . Recent imaging studies provide evidence for dysregulated presynaptic membrane expression of the dopamine transporter in first-episode psychosis. 62 Postsynaptically, in synaptic spines, CME facilitates endocytosis, trafficking and recycling of various neurotransmitter receptors with suspected roles in psychosis neuropathology. For example, dopamine receptor recycling is largely a CME-dependent process, [63] [64] [65] [66] and dopamine D2R surface expression is Published associations between each protein/gene and psychotic disorders were identified by Pubmed searches linking each protein/gene to 'schizophrenia' or 'bipolar disorder'. For the proteomic literature, the search strategy was based upon our recent review of the literature 105 and complemented by reviews of recent literature.
Genome-wide association studies (GWAS) associations refers to genes listed among the top 1000 gene associations in the SZGene database. 27 Studies labeled with (À) specifically tested for the gene/protein in question and failed to demonstrate disease-associated changes. Many clathrin-and AP-2 interactome proteins 4 have not yet been tested for associations with either disease. These include AP-1,-3,-4, epsin 1-3, HIP1R, amphiphysin 1, connecdenn, sorting nexin 9, eps15, eps15R, intersectin 1, HIV-rev interacting protein, dynamin 2, dynamin 3, ARM, Dab2, NECAP-1, AAK, and auxilin.
regulated by CME. 67 Thus, CME directly regulates dopamine receptor numbers at the postsynaptic site, known to be an important determinant of dopamine signal strength. Similarly, NMDA glutamate receptors, which are thought to be functionally impaired in psychosis, 68, 69 are endocytosed by clathrin-dependent mechanisms. 53 Other receptors that are implicated in schizophrenia such as AMPA 70, 71 and GABA(A) 72, 73 are also regulated by clathrin-dependent mechanisms.
Up-and downstream of the synapse, interactions of clathrin-interacting proteins with intracellular trafficking pathways are also well described. In axon terminals, clathrin interactors mediate the incorporation of proteins such as SNARE proteins, into synaptic vesicles, thereby indirectly modulating their functional properties. 43 SNAREs are crucial for synaptic vesicle fusion and exocytosis, and SNARErelated abnormalities are well documented in psychosis. 38, [74] [75] [76] These functions, as mentioned earlier, are mediated by BLOC-1, another constituent of clathrin-coated vesicles. Postsynaptically, clathrininteracting proteins have a part in endosomal sorting of cargo molecules through interaction with Rab proteins. 7 Clathrin-dependent processes therefore crucially contribute to the maintenance of synaptic homeostasis, and to modulation of dysbindin, BLOC-1, and SNARE function (Figure 2 ). Disturbances of the synapse are thought to be central to psychotic disorders, 58, 77 with particular emphasis on the dopamine and glutamate systems. 1 We argue that CME and clathrin-dependent protein trafficking may have an important role in synapse pathophysiology.
Altered CME may contribute to white matter pathology Oligodendroglial cells synthesize the central nervous system myelin sheath by wrapping multiple layers of specialized membrane around the axon. During active myelinogenesis, they exhibit an extraordinarily high production of membrane. 78 This requires a sophisticated membrane-trafficking machinery, 79 which involves oligodendrocytes reacting to signals of the growing neuron and adjusting the relative levels of exocytosis and endocytosis of the major myelin protein proteolipid protein. Recent data reveal that endocytosis of proteolipid protein is clathrin-dependent. 80 White matter disturbances are a widely recognized feature of schizophrenia neuropathology. 81 We speculate that altered CME during myelinogenesis could significantly contribute to these findings.
Altered CME may contribute to neurodevelopmental disturbances Endocytic recycling is important for developmental processes, especially where rapid mobilization of plasma membrane and polarized membrane growth occurs. 82 In polarized neurons, endosomal membrane trafficking is required for activity-induced growth and remodeling of dendritic spines. 83 Neurite outgrowth and neurite extension are regulated by clathrin-dependent recycling in endosomes and coordinated exocytosis of a specialized endocytic compartment. [84] [85] [86] A recent study demonstrated that CME drives repulsive growth cone guidance in developing axons, 87 suggesting that the balance between membrane addition and removal dictates bidirectional axon guidance during brain development. The concept that neurodevelopmental disturbances significantly contribute to psychotic disorders 88 is well supported by epidemiological, genetic, developmental and imaging studies. 89 We argue that disturbed endocytic mechanisms could be one important underlying molecular mechanism.
Antipsychotic medications and lithium directly interact with clathrin-interacting proteins
Phenothiazines are strong inhibitors of CME Phenothiazines such as chlorpromazine and trifluoperazine were the first molecules found to have specific clinical antipsychotic efficacy, and were the cornerstone of psychosis treatment for several decades since their discovery in the 1940s. 90 They strongly inhibit CME by preventing the binding of adaptor protein complexes such as AP-2 to the plasma membrane, thereby effectively abolishing the formation of coated pits. 91 They also appear to relocate clathrin/AP-2 complexes from the plasma membrane to intracellular endosomal structures. 92 First-and second-generation antipsychotics and lithium directly interact with clathrin-interacting protein b-arrestin Antipsychotic agents of various drug classes differ considerably in their antagonistic properties to D2Rs and their effects on D2R signaling. In search of a common mechanism that may explain their clinical effectiveness, Masri et al. 93 recently demonstrated that first-and second-generation antipsychotics strongly antagonize recruitment of the clathrin-interacting protein b-arrestin to D2Rs following stimulation with dopamine or quinpirole. The authors further demonstrated that this inhibition effectively prevented b-arrestin-mediated signaling through the Akt/glycogen synthase kinase-3 pathway. 94 It is likely that the observed effects influence receptor endocytosis via CME on some level, given its primary function as an endocytic adaptor. Indeed, inhibition of clathrin-mediated, dopamine-induced D2R internalization has been reported for the typical antipsychotic haloperidol. 95 For other classes of antipsychotics, effects on receptor endocytosis are less clear. 96 The mood stabilizer lithium, which influences many signaling pathways, 97, 98 has similar effects on b-arrestin and the Akt/glycogen synthase kinase-3 pathway. 99 Interestingly, clomipramine and its active metabolite desmethylclomipramine have recently been shown to potently inhibit autophagic flux. from proteins to organelles with direct links to the endosome-lysosome pathway.
Polyunsaturated omega-3 fatty acids modulate CME Recent data support clinical effectiveness for polyunsaturated omega-3 fatty acids (PUFAs) in preventing progression from pre-psychotic at-risk states to first-episode psychosis. 101 A large epidemiologic investigation of over 33 000 women concluded that high intake of omega-3 fatty acids during pregnancy decreases the incidence of schizophrenia in the offspring. 102 In vitro, PUFAs stimulate CME and synaptic vesicle recycling. 103 In cellular membranes, PUFAs act as cone-shaped lipids that induce a positive curvature of the membrane leaflet, 104 thereby enhancing membrane trafficking. 103 It is thus possible that PUFAs exert at least some of their protective effects through stabilization of disordered membrane endocytosis.
Clathrin-interacting proteins and other neuropsychiatric disorders
The reported changes of clathrin-interacting proteins apply equally to schizophrenia and bipolar disorder, 105 which echoes growing evidence suggesting that schizophrenia and bipolar disorder share genetic vulnerabilities. 106, 107 Clathrin interactome Figure 2 Pre-and postsynaptic functions associated with psychosis neuropathology are dependent on clathrin-mediated mechanisms. Presynaptic vesicles are recycled from the synapse via clathrin-mediated endocytosis (CME). Surface expression of the dopamine transporter (DAT) is regulated through CME. Postsynaptically, endocytosis and endosomal trafficking of G-protein-coupled receptors such as D2 and GABA(A) as well as heteromers such as N-methyl-D-Aspartate (NMDA) and AMPA receptors are CME-dependent. Trafficking of the SNARE protein complex pre-and postsynaptically is CME-mediated. dysfunction may therefore be a risk factor for psychotic illness generally, rather than for any one specific disorder. This point is reinforced by observations in other neuropsychiatric disorders. In Huntington's disease, where psychosis can be prominent at first presentation, 108 the mutant protein interacts with Rab5 to regulate the fusion of clathrin-derived endocytic vesicles. 109 In Alzheimer's disease, clathrin-dependent endocytosis of amyloid precursor protein is believed to be the rate-limiting step in the production of amyloid-b peptide whose accumulation is the hallmark of the disorder. [110] [111] [112] Further, clathrin was found to interact with two proteins critically involved in the pathogenesis of Parkinson's disease, a-synuclein and DJ-1. 113 Rab proteins as a family have roles in membrane trafficking, synaptic function, neurite growth and brain development, and as such they make plausible candidates to be involved in neuropsychiatric disorders (for review see ref. 114 ). Rab7 and Rab11 act downstream of CME on clathrin-coated vesicles. Rab7 mutations are responsible for Charcot-Marie-Toothtype 2B neuropathy. 115 Interestingly, Charcot-MarieTooth is also associated with another protein with CME activity, Dynamin 2.
116 Rab 39B is believed to be involved in endosomal trafficking and to have roles in neurite arborization and growth cone development. 117 It has been associated with mental retardation, epilepsy and autism. 118 Taken together, these observations show that alterations of proteins even remotely linked to clathrin-dependent processes can lead to significant disturbances of the nervous system. It is intriguing to speculate that perturbance of the clathrin interactome increases the likelihood of developing psychosis as part of the phenotype in any disorder, even if the underlying genetic lesion results in more obvious changes in other pathways. This idea would also resonate with the polygenic concept of schizophrenia and bipolar disorder, where a wide range of genetic alterations of small effect appear to produce similar phenotypes. 1 
Limitations in evidence for role of the clathrin interactome in psychotic disorders
The involvement of clathrin interactors in several key areas of psychosis is intriguing, but not all lines of evidence support this view. For example, while proteomic studies of psychotic disease individually have identified many members of the clathrin interactome, overlap between the results is incomplete. Among CME core proteins, only dynamin-1 has been found consistently dysregulated across several investigations and brain regions, 105 and postmortem western blot analyses of dynamin 1 expression in several brain areas of subjects with bipolar disorder failed to demonstrate altered protein levels. 119 Further, as mentioned above, mutations of dynamin 2 lead to peripheral neuropathy but not psychotic symptoms or cognitive decline. 120 This raises doubts over the roles of dynamins, in general, in psychosis pathogenesis, and may be due to their involvement in several nonendocytic pathways. 4 Further, while the effects of most, but not all, antipsychotic medications on barrestin and D2R internalization are well documented (see above), the consequences on CME are less clear. 96 Further work is needed to clarify the expression levels of CME and trafficking proteins in schizophrenia brain and tissues, and the effects of antipsychotic drugs on their expression and function.
In pulling together a vast amount of information in an integrative fashion, as was done in our literature search, there undoubtedly remains a range of uncertainty associated with individual aspects. For example, protein-protein interaction data could come from human or nonhuman species, or be based on interactions characterized extensively in vivo, or based on yeast two-hybrid screens. The clathrin interactome is likely to include a variety of accessory proteins in different cell types, and alternative isoforms for many CME genes have been described in eukaryotic cells. 4 Clarification of these concerns in relation to psychotic disorders will become important in future investigations.
From endocytosis to membrane-and protein trafficking: CME may be only one piece of the puzzle
The trafficking of membranes and proteins within cells, and their cycling to and from sites of action are complex processes, which are tightly regulated. Proteins move through several organelles on their journey from synthesis at the nucleus to their final destination. Owing to the interdependence and mutual control of these steps, disturbances at any point of the journey are likely to lead to knock-on effects up-and downstream. The following observations illustrate that the endocytic mechanisms discussed so far must be put into a wider context.
Protein-scaffold interactions
Dynamic trafficking of receptor proteins from the endoplasmatic reticulum through the golgi network to the neuronal surface involves interactions with synaptic scaffolding proteins such as SAP-102, PSD-95, PSD-93 and SAP-97. These scaffolds mediate insertion of the receptors into the membrane, and regulate receptor subunit composition at the cell surface (for overview see ref. 53 ). Transcript analysis in postmortem schizophrenia and bipolar disorder brains has revealed decreased levels of SAP-97, SAP-102 and PSD 95. 24, 25, 121 The gene DLG1, which encodes SAP-97, has been strongly linked to schizophrenia susceptibility. 122 A similar link exists for DLG4, which encodes PSD-95.
123
Protein phosphorylation and endocytosis Clathrin-dependent endocytosis of postsynaptic receptor proteins is mediated primarily by phosphorylation of internalization motifs within receptor molecules. Abnormalities of the phosphorylation steps during NMDA receptor endocytosis have been demonstrated in psychosis. 124, 125 Further, schizophrenia candidate gene neuregulin 1 126 influences phosphorylation of receptor molecules, thus regulating their endocytosis rates. 127 Proteasomal degradation (and degradation via autophagy) Many receptor proteins undergo activity-dependent protein degradation by the ubiquitin-proteasome system. 128 In postmortem schizophrenia and bipolar disorder tissue, several studies found dysregulation of ubiquitine-proteasome-related genes. [129] [130] [131] [132] [133] [134] Similarly, recent genetic investigations found evidence for an association of the ubiquitin-proteasome pathway with psychotic disorders, as well as correlations of several ubiquitin-proteasome pathway proteins with clinical dimensions in schizophrenia. 135 Phosphoinositides and the endocytic pathway Phosphatidylinositol 4,5-bisphosphate (PIP 2 ), a membrane-bound phosphoinositide protein, binds the AP2 complex during the initial stages of CME. 136, 137 Depleting PIP 2 in living cells results in AP2 mislocalization and inhibition of endocytosis.
138-142 PIP 2 is important in psychotic disorders, as it is part of the phosphoinositide-protein kinase C (PI-PKC) pathway, which is inhibited by many psychotropic medications. Findings from postmortem studies provide evidence for PI-PKC hyperfunction in psychosis. This hyperfunction may in part be counteracted by the mood stabilizer lithium, which was shown to deplete PIP 2 though reduction of brain inositol. 143 It is possible that phosphoinositide disturbances contribute to the proposed CME alterations in psychosis.
Caveolin-dependent endocytosis and psychiatric disorders Disruption of the scaffolding protein Caveolin-1 was recently identified as a rare structural variant associated with schizophrenia. 144 Caveolins are integral parts of lipid raft microdomains in the cellular membrane, which can facilitate ligand-induced, clathrin-independent endocytosis of a range of neurotransmitter receptors. 145 Experiments in Caveolin-1 knockout animals show that disruption of the gene results in behavioral effects in keeping with propsychotic states. 146 This suggests that clathrin-independent mechanisms of receptor endocytosis and trafficking can have a part in generation of the psychosis phenotype.
The role of endosomal trafficking As described previously, the consequences of functional disruption of the BLOC-1 complex are well documented, and have attracted much attention from the schizophrenia field due to the genetic association of BLOC components dysbindin and muted with the disorder. BLOC-1 regulates membrane protein targeting to synaptic vesicles, lysosomes and lysosome-related organelles from transferrin-receptorpositive endosomes. 44, 147, 148 Taking BLOC-1 as a starting point, Ryder and Faundez have reviewed the genetic literature for evidence supporting endosomal trafficking pathways in schizophrenia, 23 and concluded that an 'endosomal hypothesis' accommodates the polygenetic nature of genetic association data as well as neurodevelopmental aspects of the disease. We support this view in part; however, we would stress that endosomal trafficking defects may only represent one piece of a larger, pan-cellular endocytosis and trafficking problem.
Conclusion
The depth and breadth of the findings in support of trafficking and CME abnormalities in psychosis provide support for a new understanding of schizophrenia as a disorder of membrane and receptor trafficking. Compellingly, the data converge from such broad research areas as genetics, postmortem brain proteomics, neuropharmacology, receptor trafficking, synaptic plasticity and developmental neuroscience. The data implicate synaptic vesicle and receptor endocytosis both at presynaptic and postsynaptic sites. Both clathrin-dependent, particularly, and -independent mechanisms are involved.
Any process that contributes in a significant way to the pathophysiology of schizophrenia should explain core aspects of the disease such as neurodevelopmental aspects, synaptic pathology, heritability and neuroleptic response. Thus, the influence of CME on synaptic plasticity, 53 axon growth cone development 84 and myelination 80 is important. The proteomic data were the starting point for this novel hypothesis concerning CME and schizophrenia, and these data implicated 'core' proteins of the CME interactome, namely dynamin1, amphiphysin, AP-2 and HSC70. Given the clinical efficacy of antipsychotic medications, it is reasonable to expect that these drugs would influence CME. While this has not yet been specifically assessed, it has been shown that these agents influence core members of the clathrin interactome. 93 Further, lithium and PUFAs also influence CME. 99, 103 In terms of heritability, many genes have roles either directly or indirectly in CME or cellular protein trafficking, including Stonin 2, Epsin 4, DTNBP1, muted, neuregulin, ERBB4, PP2B, calcineurin, KCNH2, DLG1 and 4. We consider that this evidence is compelling and points to a need to seriously consider the potential influence of this process in psychosis.
CME is central to so many essential cellular processes 3 that the effect of any dysregulation, however subtle, could be widespread and beyond those typically understood to be a part of psychosis. For example, CME has important roles in endocrine function 149 and the possibility that reported endocrine abnormalities in schizophrenia are a consequence of altered CME should be considered. Equally, cytoskeletal proteins are implicated in schizophrenia, 16, 18, 19 and of these, actin is particularly influenced by CME. 150 Thus, considering schizophrenia as a disorder of CME and trafficking may allow us to gain new insights into the disorder. Future work will need to clarify whether the CME model relates to risk of illness, or direct causation. As discussed in a recent commentary, there are 'too many roads not taken'. 151 We propose that discovery proteomics has provided candidates that may allow us to understand the disease pathogenesis from a different angle, that of CME.
The hypothesis that schizophrenia is a disorder of altered trafficking is not a new one and has been considered previously. 23 However, the hypothesis that altered CME is responsible for the pathophysiology of schizophrenia is a novel hypothesis. On balance, we show evidence that both processes are implicated, for the evidence extends from clathrin interactome proteins (Table 1) to clathrin-associated and downstream trafficking proteins that interact with both clathrin-dependent and -independent trafficking processes (Supplementary Table 1 ). The evidence also supports the view that alterations in CME and membrane trafficking are associated with a neuropsychiatric vulnerability generally, 114 although links are yet to be firmly established. 5 Future work should consider systemic as well as neurological measures of altered clathrin-dependent and clathrin-independent endocytosis. For example, do serum 152 and brain alterations 16 in the iron-binding protein transferrin represent a biomarker of altered CME in psychosis, and could iron dysregulation, 153 induced by altered CME, lead to abnormal myelin development in schizophrenia? Animal models involving dysregulated CME function and trafficking need to be explored as potential animal models of schizophrenia. For example, exploring the behavioral phenotype of inhibitors of CME such as dynasore 154 may offer insights into psychosis and antipsychotic effects. The central role of CME in viral entry into cells 15 is intriguing and raises the possibility that CME abnormalities may lead to an increased vulnerability to prenatal viral infection, itself a risk factor for schizophrenia. 155, 156 Despite the appreciation of the high cost of schizophrenia to society and the inadequacy of current treatments, drug discovery in schizophrenia is currently at an impasse, and major big pharmaceutical companies are leaving this area of drug development. 157, 158 Against this background, we propose that the manipulation of CME offers a genuinely novel 'pharmacological toolbox' 91 for the treatment of psychosis. Further, the therapeutic effects of the modulation of CME may not be specific to psychosis but apply more generally to other systemic neurological and neuropsychiatric disorders. 5 To our knowledge, the process of CME has not been probed previously for therapeutic effects in psychosis, or relevant animal models, and in our view such work may offer wonderful opportunities in the future.
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